
1. Infection. 2020 Aug 4. doi: 10.1007/s15010-020-01495-4. [Epub ahead of print]

Mycobacterium bovis infection of an aortobifemoral bypass graft with
Streptococcus intermedius superinfection after intravesical bacillus
Calmette-Guérin immunotherapy for bladder cancer.

Dubert M(1)(2), Abihssira S(3), Diamantis S(4), Guenin R(5), Messaoudi R(6), Roux
AL(7), Rouis K(8), Lillo A(9), Surgers L(10)(11), Douard R(12), Julia P(3),
Lebeaux D(13)(14).

Author information: 
(1)Université de Paris, 75006, Paris, France. marie.dubert@aphp.fr.
(2)Service de Microbiologie, Unité Mobile D'Infectiologie, AP-HP, Hôpital
Européen Georges Pompidou, 20 rue Leblanc, 75015, Paris, France.
marie.dubert@aphp.fr.
(3)Service de Chirurgie Vasculaire, Hôpital Européen Georges Pompidou, AP-HP,
Paris, France.
(4)Service de Maladies Infectieuses, Groupe Hospitalier Sud Ile de France, Melun,
France.
(5)Service de médecine nucléaire, Centre de Médecine Nucléaire, 77 Santepole,
Melun, France.
(6)Service d'urologie, Clinique Saint Jean de L'Hermitage, Dammarie-Les-Lys,
Melun, France.
(7)Service de Microbiologie, Hôpital Ambroise Paré, AP-HP, Boulogne-Billancourt, 
Paris, France.
(8)Université de Paris, 75006, Paris, France.
(9)Centre de Pharmacovigilance, Hôpital Européen Georges Pompidou, AP-HP, Paris, 
France.
(10)Service de Maladies Infectieuses, Hôpital Saint Antoine, AP-HP Sorbonne
Université, Paris, France.
(11)Sorbonne université, CIMI équipe 13, INSERM U1135, 75005, Paris, France.
(12)Service de Chirurgie générale, Digestive Et Oncologique, Hôpital Européen
Georges Pompidou, AP-HP, Paris, France.
(13)Université de Paris, 75006, Paris, France. david.lebeaux@aphp.fr.
(14)Service de Microbiologie, Unité Mobile D'Infectiologie, AP-HP, Hôpital
Européen Georges Pompidou, 20 rue Leblanc, 75015, Paris, France.
david.lebeaux@aphp.fr.

BACKGROUND: The Bacillus Calmette-Guerin (BCG) is a life-attenuated form of
Mycobacterium bovis widely used as immunotherapy for localized bladder cancer.
Adverse reactions to intravesical BCG instillations are rare.
CASE: We describe a 70-year-old man with a history of an aortobifemoral bypass
graft, placement of a synthetic mesh for treatment of a ventral hernia and, most 
recently, superficial bladder cancer treated with BCG therapy. Ten months after
his final intravesical BCG instillation, he complained of fever and asthenia.
After 12 months of investigation, he was diagnosed with Mycobacterium bovis
infection of his aortobifemoral bypass graft and abdominal mesh, with
Streptococcus intermedius superinfection. The bypass graft was excised and
replaced with an in situ arterial allograft, the abdominal mesh was removed, and 
treatment started with amoxicillin, isoniazid, rifampicin and ethambutol. Several
additional vascular interventions were needed for allograft degradation, but
12 months after the final procedure, outcome was good.
DISCUSSION AND CONCLUSIONS: Among 35 cases of mycotic aneurysm reported after BCG
therapy in the last 10 years, only one involved a vascular prosthesis. Surgical
repair of such aneurysms using prosthetic grafts is commonly performed,
associated with anti-mycobacterial treatment. Prognosis is poor with mortality of
14% (4/35) and a 26% rate of aneurysm recurrence under treatment (9/35).

DOI: 10.1007/s15010-020-01495-4 
PMID: 32749595 

